Business UpdateMay 19, 2026, 08:02 AM
Ardelyx to Participate in Jefferies Global Healthcare Conference
AI Summary
Ardelyx Inc. announced its participation in a fireside chat at the Jefferies Global Healthcare Conference 2026. The event is scheduled for June 3 at 9:55 a.m. ET in New York, with a live webcast and replay available on the company's investor relations website. Ardelyx is a commercial-stage biopharmaceutical company with two approved products, IBSRELA and XPHOZAH, and a pipeline including IBSRELA for chronic idiopathic constipation and RDX10531.
Key Highlights
- Ardelyx to participate in a fireside chat at the Jefferies Global Healthcare Conference 2026.
- The fireside chat is scheduled for June 3 at 9:55 a.m. ET in New York.
- A live webcast will be available on the Ardelyx investor relations website.
- A replay of the webcast will be accessible after the event.
- Ardelyx has two commercial products: IBSRELA and XPHOZAH.
- The company's pipeline includes Phase 3 IBSRELA for CIC and RDX10531.
Price Impact
More from ARDX